PURPOSE: Ventilator-associated pneumonia (VAP) is associated with increased morbidity, mortality and costs. We describe an active, multifaceted implementation of a VAP prevention bundle designed to improve staff compliance with evidence-based actions and reduce the incidence of VAP. METHOD: A 'VAP prevention bundle' was designed then implemented, first passively, then actively, as defined by a multimodal programme incorporating staff education, process measurement and outcome measurement and feedback to staff and organisational change. RESULTS: Compliance with the VAP prevention bundle increased after active implementation. VAP incidence fell significantly from 19.2 to 7.5 per 1,000 ventilator days. Rate difference (99% CI) = 11.6 (2.3-21.0) per 1,000 ventilator days; rate ratio (99% CI) = 0.39 (0.16, 0.96). CONCLUSIONS: An active implementation programme increased staff compliance with evidence-based interventions and was associated with a significant reduction in VAP acquisition.
PURPOSE: Ventilator-associated pneumonia (VAP) is associated with increased morbidity, mortality and costs. We describe an active, multifaceted implementation of a VAP prevention bundle designed to improve staff compliance with evidence-based actions and reduce the incidence of VAP. METHOD: A 'VAP prevention bundle' was designed then implemented, first passively, then actively, as defined by a multimodal programme incorporating staff education, process measurement and outcome measurement and feedback to staff and organisational change. RESULTS: Compliance with the VAP prevention bundle increased after active implementation. VAP incidence fell significantly from 19.2 to 7.5 per 1,000 ventilator days. Rate difference (99% CI) = 11.6 (2.3-21.0) per 1,000 ventilator days; rate ratio (99% CI) = 0.39 (0.16, 0.96). CONCLUSIONS: An active implementation programme increased staff compliance with evidence-based interventions and was associated with a significant reduction in VAP acquisition.
Authors: N Salahuddin; A Zafar; L Sukhyani; S Rahim; M F Noor; K Hussain; S Siddiqui; M Islam; S J Husain Journal: J Hosp Infect Date: 2004-07 Impact factor: 3.926
Authors: H Bryant Nguyen; Stephen W Corbett; Robert Steele; Jim Banta; Robin T Clark; Sean R Hayes; Jeremy Edwards; Thomas W Cho; William A Wittlake Journal: Crit Care Med Date: 2007-04 Impact factor: 7.598
Authors: Hilary M Babcock; Jeanne E Zack; Teresa Garrison; Ellen Trovillion; Marilyn Jones; Victoria J Fraser; Marin H Kollef Journal: Chest Date: 2004-06 Impact factor: 9.410
Authors: J L Vincent; D J Bihari; P M Suter; H A Bruining; J White; M H Nicolas-Chanoin; M Wolff; R C Spencer; M Hemmer Journal: JAMA Date: 1995 Aug 23-30 Impact factor: 56.272
Authors: Sonia O Labeau; Dominique M Vandijck; Nele Brusselaers; David De Wandel; Dirk P Vogelaers; Stijn I Blot Journal: Intensive Care Med Date: 2009-07-31 Impact factor: 17.440
Authors: Ashley W Collinsworth; Elisa L Priest; Claudia R Campbell; Eduard E Vasilevskis; Andrew L Masica Journal: J Intensive Care Med Date: 2014-10-27 Impact factor: 3.510
Authors: Anke Kohlenberg; Frank Schwab; Michael Behnke; Christine Geffers; Petra Gastmeier Journal: Intensive Care Med Date: 2010-03-23 Impact factor: 17.440
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2010-01-08 Impact factor: 17.440